Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_208
Snippet: CLINICAL EFFICACY AND SAFETY OF ZONISAMIDE MONOTHERAPY IN DOGS WITH NEWLY DIAGNOSED IDIOPATHIC EPILEPSY. Akinori Nomura 1 , Miyoko Saito 2 , Daisuke Hasegawa 3 , Naoyuki Watanabe 4 , Keiko Uchida 5 , Seiichi Okuno 6 , Masahiro Nakai 1 , Kensuke Orito 2 . 1 DS Pharma Animal Health Co., Ltd., Osaka, Japan, 2 Azabu University, kanagawa, Japan, 3 Nippon Veterinary and Life Science University, Tokyo, Japan, 4 Watanabe Animal Hospital, Shizuoka, Japan,.....
Document: CLINICAL EFFICACY AND SAFETY OF ZONISAMIDE MONOTHERAPY IN DOGS WITH NEWLY DIAGNOSED IDIOPATHIC EPILEPSY. Akinori Nomura 1 , Miyoko Saito 2 , Daisuke Hasegawa 3 , Naoyuki Watanabe 4 , Keiko Uchida 5 , Seiichi Okuno 6 , Masahiro Nakai 1 , Kensuke Orito 2 . 1 DS Pharma Animal Health Co., Ltd., Osaka, Japan, 2 Azabu University, kanagawa, Japan, 3 Nippon Veterinary and Life Science University, Tokyo, Japan, 4 Watanabe Animal Hospital, Shizuoka, Japan, 5 AC-plaza Kariya Animal Hospital, Tokyo, Japan, 6 Animal Clinic Kobayashi, Saitama, Japan Zonisamide is an antiepileptic medication and is used for canine and feline epilepsy. Information on the clinical efficacy as monotherapy is, however, limited. In this study, anticonvulsant efficacy and safety of zonisamide (Consave Ã’ ) were evaluated in a multicenter open-label uncontrolled study in dogs with newly diagnosed idiopathic epilepsy.
Search related documents:
Co phrase search for related documents- clinical efficacy and open label: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- clinical efficacy and uncontrolled study: 1, 2
- feline epilepsy and idiopathic epilepsy: 1
- idiopathic epilepsy and open label: 1
- open label and uncontrolled study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date